The global hyperbaric oxygen therapy devices market size is expected to reach USD 4.9 billion by 2030 registering a CAGR of 4.9% over the forecast period, according to a new report by Grand View Research, Inc.Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.
Although the off-label usage of hyperbaric oxygen therapy equipment in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.
According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.
Request a free sample copy or view report summary: Hyperbaric Oxygen Therapy Devices Market Report
The global hyperbaric oxygen therapy devices market size was estimated at USD 3.3 billion in 2022 and is anticipated to grow at a CAGR of 4.9% from 2023 to 2030.
The Monoplace HBOT devices segment accounted for the largest revenue share in 2022.
The hyperbaric oxygen therapy (HBOT) technique enhances the effectiveness of leukocytes, especially in the wound site, and hinders the toxic effect of carbon monoxide (CO) and cyanide. Growing acceptance of this technology globally is one of the key factors expected to boost the market during the forecast period.
The Asia Pacific segment is expected to grow at the fastest CAGR of 5.4% during the forecast period. This region is anticipated to deliver enormous growth due to increasing per capita income, a growing medical tourism industry, and rising public awareness regarding the benefits of HBOT devices.
Grand View Research has segmented the global hyperbaric oxygen therapy equipment market on the basis of product, application, and region:
Hyperbaric Oxygen Therapy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Monoplace HBOT devices
Multiplace HBOT devices
Topical HBOT devices
Hyperbaric Oxygen Therapy Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Wound healing
Decompression sickness
Infection treatment
Gas embolism
Others
Hyperbaric Oxygen Therapy Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Hyperbaric Oxygen Therapy Devices Market
Fink Engineering
ETC Hyperbaric Chambers (Environmental Tectonics Corporation)
HAUX-LIFE-SUPPORT
Gulf Coast Hyperbarics, Inc.
HEARMEC
IHC Hytech B.V. (Royal IHC)
Hyperbaric SAC
Sechrist Industries, Inc.
OxyHeal International
SOS Group Global Ltd
"The quality of research they have done for us has been excellent..."